XSNX — NovAccess Global Income Statement
0.000.00%
- $0.01m
- $2.20m
Annual income statement for NovAccess Global, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5.92 | 2.7 | 1.42 | 2.47 | 1.4 |
| Operating Profit | -5.92 | -2.7 | -1.42 | -2.47 | -1.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.99 | -2.51 | -1.72 | -4.72 | -2.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.99 | -2.51 | -1.72 | -4.72 | -2.66 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -6.77 | -2.51 | -1.72 | -4.72 | -2.66 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.77 | -2.51 | -1.72 | -4.77 | -2.66 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.19 | -0.223 | -0.101 | -0.229 | -0.048 |